The
United States Health authorities have ease safety restrictions on an
experimental drug to treat Ebola, a move that could clear the way for
it to be used in patients infected in the virus.
TKM-Ebola,
a drug made by Canadian drug maker Tekmira Pharmaceuticals Corp said
the U.S Food and Drug Administration which it has a contract with has
modified a hold recently place on the company's drug after safety
issues emerged in human testing.
The
is coming after the FDA halted a small study of the injection in
adult to request additional safety information
Two
Americans diagnosed with Ebola were recently treated with a different
experimental drug called Zmapp made by Mapp Biopharmaceuical Inc. of
San Diego.
The
drug aims to boost the immune system's effort to fight off Ebola and
is made from antibodies produced by lab animals exposed to parts of
the virus.
The
two Americans were first treated in Liberia where the FDA does not
have authority over the use of such experimental drugs. The FDA must
grant permission to use experimental treatments in the United State
but it has no authority over the use of such drugs in other
countries.
No comments:
Post a Comment